ANI Pharmaceuticals, Inc. (ANIP) Ownership

NASDAQ Currency in USD Disclaimer

$53.39

south_east -$0.87 (-1.6%)
Day's range
$53.01
Day's range
$54.56

ANI Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 11/13/2024 2.69 M $160.47 M   100.00% 13.86%
VANGUARD GROUP INC 11/13/2024 1.35 M $80.43 M   -6.41% 6.95%
GOLDMAN SACHS GROUP INC 11/14/2024 716,069 $42.72 M   695.99% 3.69%
STATE STREET CORP 11/14/2024 703,843 $41.99 M   9.10% 3.63%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 655,310 $39.09 M   3.98% 3.38%
RANGER INVESTMENT MANAGEMENT, L.P. 11/04/2024 589,688 $35.18 M   46.42% 3.04%
PACER ADVISORS, INC. 11/12/2024 568,343 $33.91 M   23,259.76% 2.93%
JPMORGAN CHASE & CO 11/08/2024 554,835 $33.10 M   159.29% 2.86%
GLOBAL ALPHA CAPITAL MANAGEMENT LTD. 11/08/2024 536,450 $32.00 M   1.80% 2.76%
CITADEL ADVISORS LLC 11/14/2024 529,877 $31.61 M   43.86% 2.73%
MILLENNIUM MANAGEMENT LLC 11/14/2024 529,752 $31.61 M   130.25% 2.73%
DEEP TRACK CAPITAL, LP 11/14/2024 504,828 $30.12 M   8.31% 2.60%
MACQUARIE GROUP LTD 11/14/2024 491,647 $29.33 M   26.69% 2.53%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 11/08/2024 474,828 $28.33 M   -2.97% 2.45%
TANG CAPITAL MANAGEMENT LLC 11/14/2024 450,000 $26.85 M   0.00% 2.32%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 425,225 $25.37 M   4.24% 2.19%
MORGAN STANLEY 11/14/2024 401,329 $23.94 M   48.45% 2.07%
UBS GROUP AG 11/14/2024 286,488 $17.09 M   796.00% 1.48%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2024 269,000 $16.05 M   100.00% 1.39%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 250,346 $14.94 M   3.67% 1.29%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 245,102 $14.62 M   56.31% 1.26%
AMERIPRISE FINANCIAL INC 11/14/2024 237,219 $14.15 M   1.66% 1.22%
THOMPSON SIEGEL & WALMSLEY LLC 11/12/2024 230,159 $13.73 M   17.58% 1.19%
BANK OF MONTREAL /CAN/ 11/13/2024 221,896 $13.04 M   100.00% 1.14%
INVESCO LTD. 11/12/2024 220,359 $13.15 M   -29.17% 1.14%
NOMURA HOLDINGS INC 11/14/2024 210,624 $12.57 M   100.00% 1.09%
ROYAL BANK OF CANADA 11/14/2024 210,487 $12.56 M   4,305.34% 1.08%
MIZUHO MARKETS AMERICAS LLC 11/06/2024 195,613 $11.67 M   100.00% 1.01%
KENNEDY CAPITAL MANAGEMENT LLC 11/14/2024 188,807 $11.26 M   -4.67% 0.97%
ASSENAGON ASSET MANAGEMENT S.A. 10/23/2024 186,179 $11.11 M   149.68% 0.96%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 182,028 $10.86 M   -42.96% 0.94%
LOOMIS SAYLES & CO L P 11/13/2024 174,617 $10.42 M   -3.76% 0.90%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2024 157,958 $9.42 M   53.35% 0.81%
WOODLINE PARTNERS LP 11/14/2024 156,488 $9.34 M   100.00% 0.81%
BARCLAYS PLC 11/19/2024 143,033 $8.53 M   1,681.23% 0.74%
BANK OF NEW YORK MELLON CORP 11/12/2024 119,428 $7.13 M   -8.94% 0.62%
D. E. SHAW & CO., INC. 11/14/2024 108,621 $6.48 M   1,139.97% 0.56%
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC 11/12/2024 100,899 $5.90 M   -5.97% 0.52%
PRINCIPAL FINANCIAL GROUP INC 10/31/2024 89,961 $5.37 M   6.93% 0.46%
AMERICAN CENTURY COMPANIES INC 11/12/2024 87,487 $5.22 M   -12.36% 0.45%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2024 75,705 $4.52 M   -51.78% 0.39%
GREAT LAKES ADVISORS, LLC 11/04/2024 70,636 $4.21 M   25.95% 0.36%
MARATHON CAPITAL MANAGEMENT 11/14/2024 70,045 $4.18 M   -0.36% 0.36%
BANK OF AMERICA CORP /DE/ 11/14/2024 65,576 $3.91 M   155.52% 0.34%
F/M INVESTMENTS LLC 10/29/2024 61,782 $14.09 M   100.00% 0.32%
RICE HALL JAMES & ASSOCIATES, LLC 10/28/2024 60,375 $3.60 M   -0.49% 0.31%
WEDGE CAPITAL MANAGEMENT L L P/NC 10/11/2024 58,682 $3.50 M   -5.29% 0.30%
RUBRIC CAPITAL MANAGEMENT LP 11/13/2024 56,671 $3.38 M   -90.61% 0.29%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 11/14/2024 52,080 $3.11 M   100.00% 0.27%
LEGAL & GENERAL GROUP PLC 11/14/2024 45,840 $2.73 M   3.91% 0.24%

ANI Pharmaceuticals, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of ANIP shares?

During the previous two years, 285 institutional investors and hedge funds held shares of ANI Pharmaceuticals, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 2.69 M

VANGUARD GROUP INC: 1.35 M

GOLDMAN SACHS GROUP INC: 716,069

STATE STREET CORP: 703,843

DIMENSIONAL FUND ADVISORS LP: 655,310

Ranger Investment Management, L.P.: 589,688

What percentage of ANI Pharmaceuticals, Inc. stock is owned by institutional investors?

97.43% of ANI Pharmaceuticals, Inc. stock is owned by institutional investors.

How much institutional buying is happening at ANIP ?

Institutional investors have bought a total of 23.12 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.